"当院は、768床の病床、30を超える診療科を有する神戸市域の基幹病院です。24時間365日市民の生命と健康を守る「最後の砦」としての役割を果たし続けていくとともに、癒しと安らぎの環境をあわせ持つ、21世紀にふさわしい病院を目指します。"

During the past decade, Kobe City Medical Center General Hospital conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 59 clinical trials were completed, i.e. on average, 53.6% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 39 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kobe City Medical Center General Hospital" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Janssen Research & Development, LLC" with 13 trials sponsored, "Pfizer" with 12 trials sponsored, "Bayer" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kobe City Medical Center General Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Kobe City General Hospital" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Kobe City Medical Center General Hospital" are "Multiple Myeloma" (8 trials), "Alzheimer Disease" (5 trials), "Atrial Fibrillation" (5 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Acute Ischemic Stroke" (4 trials). Many other conditions were trialed in "Kobe City Medical Center General Hospital" in a lesser frequency.

Most popular intervention types in "Kobe City Medical Center General Hospital" are "Drug" (128 trials), "Device" (9 trials), "Other" (9 trials), "Biological" (8 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Rituximab" (9 trials), "Carboplatin" (8 trials), "Paclitaxel" (8 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Kobe City Medical Center General Hospital" are 145 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Kobe City Medical Center General Hospital". undefined are not yet recruiting, 33 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Kobe City Medical Center General Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Kobe City Medical Center General Hospital, 9 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 10 trials that are defined as “Not Applicable".